content: <HTML>
  <HEAD>
       <TITLE></TITLE>
  </HEAD>
  <BODY STYLE="font: 10pt Times New Roman, Times, Serif">
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>As filed with the U.S. Securities and Exchange
  Commission on June 10, 2025</B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Registration No. 333-[_____]</B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B></B></P>
  
  <!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>
  
  <P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt"><B>UNITED STATES</B></FONT></P>
  
  <P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt"><B>SECURITIES AND
  EXCHANGE COMMISSION</B></FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Washington, D.C. 20549</B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>
  
  <P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt"><B>FORM S-8</B></FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>REGISTRATION STATEMENT UNDER THE SECURITIES
  ACT OF 1933</B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
    <TR>
      <TD STYLE="border-bottom: black 1.5pt solid; font-size: 10pt; text-align: center"><FONT STYLE="font-size: 10pt"><B>GARDEN STAGE LIMITED</B></FONT></TD></TR>
    <TR>
      <TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="font-size: 10pt"><B>(Exact name of registrant as specified in its charter)</B></FONT></TD></TR>
    </TABLE>
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
    <TR>
      <TD STYLE="vertical-align: top; width: 49%; border-bottom: black 1.5pt solid; font-size: 10pt; text-align: center"><FONT STYLE="font-size: 10pt"><B>Cayman Islands</B></FONT></TD>
      <TD STYLE="width: 2%; padding-bottom: 1.5pt; font-size: 10pt; text-align: justify">&nbsp;</TD>
      <TD STYLE="vertical-align: top; width: 49%; border-bottom: black 1.5pt solid; font-size: 10pt; text-align: center"><FONT STYLE="font-size: 10pt"><B>Not Applicable</B></FONT></TD></TR>
    <TR>
      <TD STYLE="vertical-align: top">
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(State or other jurisdiction of</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">incorporation or organization)</P></TD>
      <TD STYLE="font-size: 10pt; text-align: justify">&nbsp;</TD>
      <TD STYLE="vertical-align: top">
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(I.R.S. Employer</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Identification No.)</P></TD></TR>
    </TABLE>
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Sze Ho, CHAN</B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Chief Executive Officer, Director and </B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Interim Chief Financial Officer</B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Garden Stage Limited</B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>30<SUP>th</SUP> Floor, China Insurance Group
  Building</B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>141 Des Vouex Road Central</U></B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>Central, Hong Kong</U></B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Address, including zip code, and telephone number,
  including area code, of registrant&rsquo;s principal executive office)</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>Garden Stage Limited</U></B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>2025 Equity Incentive Plan</U></B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Full title of the plan)</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Cogency Global Inc.</B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>122 East 42nd Street, 18th Floor</B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>New York, NY 10168</B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Name and address of agent for service)</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>Tel: +852 2688 6333 </U></B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Telephone number, including area code, of agent
  for service)</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><I>Copies to:</I></B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Shane Wu, Esq. </B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Ross D. Carmel, Esq. </B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Sichenzia Ross Ference Carmel LLP</B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>1185 Avenue of the Americas, 31<SUP>st</SUP>
  Floor</B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>New York, NY 10036</B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Telephone: (212) 930-9700</B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant
  is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of &ldquo;large
  accelerated filer,&rdquo; &ldquo;accelerated filer&rdquo; and &ldquo;smaller reporting company&rdquo; in Rule 12b-2 of the Exchange Act.</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
    <TR>
      <TD STYLE="vertical-align: top; width: 40%; text-align: justify"><FONT STYLE="font-size: 10pt">Large accelerated filer</FONT></TD>
      <TD STYLE="vertical-align: bottom; width: 10%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD>
      <TD STYLE="vertical-align: top; width: 40%; text-align: justify"><FONT STYLE="font-size: 10pt">Accelerated filer</FONT></TD>
      <TD STYLE="width: 10%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD></TR>
    <TR>
      <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-size: 10pt">Non-accelerated filer</FONT></TD>
      <TD STYLE="vertical-align: bottom; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9746;</FONT></TD>
      <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-size: 10pt">Smaller reporting company</FONT></TD>
      <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9746;</FONT></TD></TR>
    <TR>
      <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Emerging growth company</FONT></TD>
      <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9746;</FONT></TD>
      <TD STYLE="text-align: justify">&nbsp;</TD>
      <TD STYLE="text-align: justify">&nbsp;</TD></TR>
    </TABLE>
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If an emerging growth company, indicate by check
  mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
  standards provided pursuant to Section 7(a)(2)(B) of the Securities Act <FONT STYLE="font-family: Times New Roman, Times, Serif">&#9744;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>
  
  <!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>
  
  <!-- Field: Page; Sequence: 1 -->
      <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
      <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
      <!-- Field: /Page -->
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXPLANATORY NOTE</B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This registration statement
  on Form S-8 (the &ldquo;Registration Statement&rdquo;) relates to an additional 5,900,000 ordinary shares, par value $0.0001 per share
  of Garden Stage Limited (the &ldquo;Registrant,&rdquo; the &ldquo;Company,&rdquo; &ldquo;we,&rdquo; &ldquo;us&rdquo; or &ldquo;our&rdquo;),
  which are issuable pursuant to awards that may be granted under our Equity Incentive Plan, as amended (the &ldquo;Plan&rdquo;). There
  may be additional shares that will become reserved for issuance as a result of the operation of the &ldquo;evergreen&rdquo; provision
  in the Plan. Under the Plan, a total of 5,900,000 ordinary shares have been reserved for issuance upon the grant of awards and exercise
  of options to directors, officers, employees and consultants of the Company and of the Company&rsquo;s affiliates, subject to increase
  under the &ldquo;evergreen&rdquo; provision in the plan. Pursuant to General Instruction E to Form S-8, the contents of the Registrant&rsquo;s
  Prior Registration Statements are incorporated herein by reference except to the extent supplemented, amended or superseded by the information
  set forth herein. Only those items of Form S-8 containing new information not contained in the earlier registration statement are presented
  herein. Only those items of Form S-8 containing new information not contained in the Prior Registration Statements are presented herein.</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>
  
  <!-- Field: Page; Sequence: 2 -->
      <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
      <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
      <!-- Field: /Page -->
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PART I</B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>INFORMATION REQUIRED IN THE SECTION 10(a) PROSPECTUS</B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Item 1. Plan Information</B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The documents containing the
  information specified in Part I, and the Note to Part I of Form S-8 will be delivered to each of the participants in accordance with Rule
  428 under the Securities Act of 1933, as amended (the &ldquo;Securities Act&rdquo;), but these documents and the documents incorporated
  by reference in this Registration Statement pursuant to Item 3 of Part II of this Registration Statement, taken together, constitute a
  Prospectus that meets the requirements of Section 10(a) of the Securities Act.</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Item 2. Registrant Information and Employee
  Plan Annual Information.</B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Upon written or oral request,
  any of the documents incorporated by reference in Item 3 of Part II of this Registration Statement (which documents are incorporated by
  reference in this Section 10(a) Prospectus) and other documents required to be delivered to eligible employers, non-employee directors
  and consultants pursuant to Rule 428(b) are available without charge by contacting: Chan Sze Ho, Chief Executive Officer of Garden Stage
  Limited, 30th Floor, China Insurance Group Building, 141 Des Voeux Road Central, Central, Hong&nbsp;Kong at +852 2688 6333.</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>
  
  <!-- Field: Page; Sequence: 3; Options: NewSection; Value: 1 -->
      <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
      <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
      <!-- Field: /Page -->
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Investment in our ordinary
  shares involves a high degree of risk. See &ldquo;Risk Factors&rdquo; contained in this prospectus, in our periodic reports filed from
  time to time with the Securities and Exchange Commission (the &ldquo;SEC&rdquo;), which are incorporated by reference in this prospectus,
  and in any applicable prospectus supplement. You should carefully read this prospectus and the documents we incorporate by reference,
  before you invest in our ordinary shares. </B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Neither the SEC nor any
  state securities commission has approved or disapproved of these securities or passed upon the adequacy or the accuracy of this prospectus.
  Any representation to the contrary is a criminal offense.</B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>The date of this Prospectus is June 10, 2025.</B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>
  
  <!-- Field: Page; Sequence: 4; Value: 1 -->
      <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
      <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
      <!-- Field: /Page -->
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>TABLE OF CONTENTS</B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
    <TR STYLE="vertical-align: top">
      <TD STYLE="padding-bottom: 1.5pt; text-align: center; width: 90%">&nbsp;</TD>
      <TD STYLE="width: 10%; border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>Page</B></FONT></TD></TR>
    <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
      <TD><FONT STYLE="font-size: 10pt"><A HREF="#a_001">Special Note Regarding Forward-Looking Statements</A></FONT></TD>
      <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">4</FONT></TD></TR>
    <TR STYLE="vertical-align: top; background-color: White">
      <TD><FONT STYLE="font-size: 10pt"><A HREF="#a_002">Risk Factors</A></FONT></TD>
      <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">5</FONT></TD></TR>
    <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
      <TD><FONT STYLE="font-size: 10pt"><A HREF="#a_003">Legal Matters</A></FONT></TD>
      <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">5</FONT></TD></TR>
    <TR STYLE="vertical-align: top; background-color: White">
      <TD><FONT STYLE="font-size: 10pt"><A HREF="#a_004">Experts</A></FONT></TD>
      <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">5</FONT></TD></TR>
    <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
      <TD><FONT STYLE="font-size: 10pt"><A HREF="#a_005">Incorporation of Documents by Reference</A></FONT></TD>
      <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">6</FONT></TD></TR>
    <TR STYLE="vertical-align: top; background-color: White">
      <TD><FONT STYLE="font-size: 10pt"><A HREF="#a_006">Disclosure of Commission Position on Indemnification for Securities Act Liabilities</A></FONT></TD>
      <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">7</FONT></TD></TR>
    </TABLE>
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>
  
  <!-- Field: Page; Sequence: 5; Value: 1 -->
      <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
      <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
      <!-- Field: /Page -->
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_001"></A>SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS</B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 35.45pt"><B><I>This prospectus and
  any prospectus supplement contains forward-looking statements, about our expectations, beliefs or intentions regarding, among other things,
  our product development efforts, business, financial condition, results of operations, strategies or prospects. In addition, from time
  to time, our representatives have made or may make forward-looking statements, orally or in writing. Forward-looking statements can be
  identified by the use of forward-looking words such as &ldquo;believe,&rdquo; &ldquo;expect,&rdquo; &ldquo;intend,&rdquo; &ldquo;plan,&rdquo;
  &ldquo;may,&rdquo; &ldquo;should&rdquo; or &ldquo;anticipate&rdquo; or their negatives or other variations of these words or other comparable
  words or by the fact that these statements do not relate strictly to historical or current matters. These forward-looking statements may
  be included in, but are not limited to, various filings made by us with the SEC, press releases or oral statements made by or with the
  approval of one of our authorized executive officers. Forward-looking statements relate to anticipated or expected events, activities,
  trends or results as of the date they are made. Because forward-looking statements relate to matters that have not yet occurred, these
  statements are inherently subject to risks and uncertainties that could cause our actual results to differ materially from any future
  results expressed or implied by the forward-looking statements. Many factors could cause our actual activities or results to differ materially
  from the activities and results anticipated in forward-looking statements, including, but not limited to, the factors summarized below.</I></B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This prospectus identifies
  important factors which could cause our actual results to differ materially from those indicated by the forward-looking statements, particularly
  those set forth under the heading &ldquo;Risk Factors,&rdquo; beginning on page 5 of this prospectus. The risk factors included in this
  prospectus are not necessarily all of the important factors that could cause actual results to differ materially from those expressed
  in any of our forward-looking statements. Given these uncertainties, you are cautioned not to place undue reliance on such forward-looking
  statements.</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">All forward-looking statements
  attributable to us or persons acting on our behalf speak only as of the date of this prospectus and are expressly qualified in their entirety
  by the cautionary statements included in this prospectus. We undertake no obligations to update or revise forward-looking statements to
  reflect events or circumstances that arise after the date made or to reflect the occurrence of unanticipated events. In evaluating forward-looking
  statements, you should consider these risks and uncertainties.</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>
  
  <!-- Field: Page; Sequence: 6; Value: 1 -->
      <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
      <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
      <!-- Field: /Page -->
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_002"></A>RISK FACTORS</B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">An investment in our Ordinary
  Shares involves risks. Prior to making a decision about investing in our ordinary shares, you should consider carefully all of the information
  contained or incorporated by reference in this prospectus, including any risks in the section entitled &ldquo;Risk Factors&rdquo; contained
  in any supplements to this prospectus and in our registration statement on Form F-3 (Registration No. 333-283618) filed on February 18,
  2025, which went effective on March 10, 2025, and in our subsequent filings with the SEC. Each of the referenced risks and uncertainties
  could adversely affect our business, operating results and financial condition, as well as adversely affect the value of an investment
  in our securities. Additional risks not known to us or that we believe are immaterial may also adversely affect our business, operating
  results and financial condition and the value of an investment in our securities.</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_003"></A>LEGAL MATTERS</B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The validity of the securities
  offered by this prospectus will be passed upon by Sichenzia Ross Ference Carmel LLP, New York, New York.</P>
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_004"></A>EXPERTS</B>&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>
  
  <P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The consolidated financial statements for the years
  ended March&nbsp;31, 2024, incorporated by reference in this prospectus have been so included in reliance on the report of J&amp;S Associate
  PLT, an independent registered public accounting firm, given on their authority as experts in accounting and auditing. The office of J&amp;S
  Associate PLT is located at B-11-14, Megan Avenue II 12, Jalan Yap Kwan Seng, 50450, Kuala Lumpur, Malaysia.</P>
  
  <P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>
  
  <P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The consolidated financial statements as of and
  for the year ended March&nbsp;31, 2023, incorporated by reference in this prospectus have been so included in reliance on the report of
  Marcum Asia CPAs LLP, an independent registered public accounting firm, given on their authority as experts in accounting and auditing.
  The office of Marcum Asia CPAs LLP is located at 7 Penn Plaza Suite 830, New York, NY 10001.</P>
  
  <P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>
  
  <P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The consolidated financial statements for the year
  ended March 31, 2022, incorporated by reference in this prospectus have been so included in reliance on the report of Friedman LLP an
  independent registered public accounting firm, given on their authority as experts in accounting and auditing. Friedman LLP was merged
  with Marcum LLP on September 1, 2022, and filed its application to withdraw the PCAOB registration on December 30, 2022.</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>
  
  <!-- Field: Page; Sequence: 7; Value: 1 -->
      <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
      <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
      <!-- Field: /Page -->
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_005"></A>INCORPORATION OF CERTAIN INFORMATION BY REFERENCE</B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The SEC allows us to &ldquo;incorporate by reference&rdquo;
  into this prospectus the documents we file with, or furnish to, it, which means that we can disclose important information to you by referring
  you to these documents. The information that we incorporate by reference into this prospectus forms a part of this prospectus, and information
  that we file later with the SEC automatically updates and supersedes any information in this prospectus. We incorporate by reference into
  this prospectus the documents listed below:</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
    <TR>
      <TD STYLE="vertical-align: bottom; width: 0.25in">&nbsp;</TD>
      <TD STYLE="vertical-align: top; width: 0.25in"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
      <TD STYLE="vertical-align: bottom; text-align: justify"><FONT STYLE="font-size: 10pt">our Annual report on&nbsp;</FONT><A HREF="http://www.sec.gov/Archives/edgar/data/1954269/000101376224003078/ea0209110-20f_garden.htm"><FONT STYLE="font-size: 10pt">Form 20-F</FONT></A><FONT STYLE="font-size: 10pt">&nbsp;for the fiscal year ended March 31, 2024, filed with the SEC on July 31, 2024;</FONT></TD></TR>
    <TR>
      <TD STYLE="vertical-align: bottom">&nbsp;</TD>
      <TD STYLE="vertical-align: top">&nbsp;</TD>
      <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD></TR>
    <TR>
      <TD STYLE="vertical-align: bottom">&nbsp;</TD>
      <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
      <TD STYLE="vertical-align: bottom; text-align: justify"><FONT STYLE="font-size: 10pt">our report of foreign private issuer on&nbsp;Form 6-K, furnished to the SEC on&nbsp;</FONT><A HREF="http://www.sec.gov/Archives/edgar/data/1954269/000121390023093093/ea189430-6k_gardenstage.htm"><FONT STYLE="font-size: 10pt">December 5, 2023</FONT></A><FONT STYLE="font-size: 10pt">,&nbsp;</FONT><A HREF="http://www.sec.gov/Archives/edgar/data/1954269/000121390024008740/ea192627-6k_gardenstage.htm"><FONT STYLE="font-size: 10pt">February 1, 2024</FONT></A><FONT STYLE="font-size: 10pt">,&nbsp;</FONT><A HREF="http://www.sec.gov/Archives/edgar/data/1954269/000121390024026883/ea0202809-6k_garden.htm"><FONT STYLE="font-size: 10pt">March 28, 2024</FONT></A><FONT STYLE="font-size: 10pt">,&nbsp;</FONT><A HREF="http://www.sec.gov/Archives/edgar/data/1954269/000121390024030619/ea0203389-6k_garden.htm"><FONT STYLE="font-size: 10pt">April 5, 2024</FONT></A><FONT STYLE="font-size: 10pt">, </FONT><A HREF="https://www.sec.gov/Archives/edgar/data/1954269/000121390025006303/ea0228527-6k_garden.htm"><FONT STYLE="font-size: 10pt">January 24, 2025</FONT></A><FONT STYLE="font-size: 10pt">, &nbsp;<A HREF="https://www.sec.gov/Archives/edgar/data/1954269/000121390025030350/ea0237673-6k_garden.htm">April 9, 2025</A> and <A HREF="https://www.sec.gov/Archives/edgar/data/1954269/000121390025031087/ea0237865-6k_garden.htm">April 11, 2025</A>;</FONT></TD></TR>
    <TR>
      <TD STYLE="vertical-align: bottom">&nbsp;</TD>
      <TD STYLE="vertical-align: top">&nbsp;</TD>
      <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD></TR>
    <TR>
      <TD STYLE="vertical-align: bottom">&nbsp;</TD>
      <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
      <TD STYLE="vertical-align: bottom; text-align: justify"><FONT STYLE="font-size: 10pt">the description of our ordinary shares contained in our registration statement on&nbsp;</FONT><A HREF="http://www.sec.gov/Archives/edgar/data/1954269/000121390023091377/ea188981-8a12b_gardenstage.htm"><FONT STYLE="font-size: 10pt">Form 8-A</FONT></A><FONT STYLE="font-size: 10pt">, filed with the SEC on November 30, 2023, and any amendment or report filed for the purpose of updating such description;</FONT></TD></TR>
    <TR>
      <TD STYLE="vertical-align: bottom">&nbsp;</TD>
      <TD STYLE="vertical-align: top">&nbsp;</TD>
      <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD></TR>
    <TR>
      <TD STYLE="vertical-align: bottom">&nbsp;</TD>
      <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
      <TD STYLE="vertical-align: bottom; text-align: justify"><FONT STYLE="font-size: 10pt">any future annual reports on Form 20-F filed with the SEC after the date of this prospectus and prior to the termination of the offering of the securities offered by this prospectus; and</FONT></TD></TR>
    <TR>
      <TD STYLE="vertical-align: bottom">&nbsp;</TD>
      <TD STYLE="vertical-align: top">&nbsp;</TD>
      <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD></TR>
    <TR>
      <TD STYLE="vertical-align: bottom">&nbsp;</TD>
      <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
      <TD STYLE="vertical-align: bottom; text-align: justify"><FONT STYLE="font-size: 10pt">any future reports of foreign private issuer on Form 6-K that we furnish to the SEC after the date of this prospectus that are identified in such reports as being incorporated by reference into the registration statement of which this prospectus forms a part.</FONT></TD></TR>
    </TABLE>
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our March 31, 2024, Annual Report contains a description
  of our business primarily through our subsidiaries in Hong Kong and audited consolidated financial statements with reports by our independent
  auditors. The consolidated financial statements are prepared and presented in accordance with U.S. GAAP.</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Any reports filed by us with the SEC after the
  date of this prospectus and before the date that the offering of securities by means of this prospectus is terminated will automatically
  update and, where applicable, supersede any information contained in this prospectus or incorporated by reference in this prospectus.
  This means that you must look at all of the SEC filings that we incorporate by reference to determine if any of the statements in this
  prospectus or in any documents incorporated by reference have been modified or superseded. Unless expressly incorporated by reference,
  nothing in this prospectus shall be deemed to incorporate by reference information furnished to, but not filed with, the SEC.</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We will provide without charge to any person (including
  any beneficial owner) to whom this prospectus is delivered, upon oral or written request, a copy of any document incorporated by reference
  in this prospectus but not delivered with the prospectus (except for exhibits to those documents unless a documents states that one of
  its exhibits is incorporated into the document itself). Such request should be directed to: Garden Stage Limited, 30th Floor, China Insurance
  Group Building, 141 Des Voeux Road Central, Central, Hong&nbsp;Kong; Tel: +852 2688 6333.</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>
  
  <!-- Field: Page; Sequence: 8; Value: 1 -->
      <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
      <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
      <!-- Field: /Page -->
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_006"></A>DISCLOSURE OF COMMISSION POSITION ON INDEMNIFICATION</B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>FOR SECURITIES ACT LIABILITIES</B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Insofar as indemnification
  for liabilities arising under the Securities Act may be permitted to directors, officers or persons controlling the registrant, the registrant
  has been informed that in the opinion of the SEC such indemnification is against public policy as expressed in the Securities Act and
  is therefore unenforceable.</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B></B></P>
  
  <!-- Field: Page; Sequence: 9; Value: 1 -->
      <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
      <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
      <!-- Field: /Page -->
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>WHERE YOU CAN FIND MORE INFORMATION</B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>
  
  <P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">As permitted by SEC rules, this prospectus omits
  certain information and exhibits that are included in the registration statement of which this prospectus forms a part. Since this prospectus
  may not contain all of the information that you may find important, you should review the full text of these documents. If we have filed
  a contract, agreement, or other document as an exhibit to the registration statement of which this prospectus forms a part, you should
  read the exhibit for a more complete understanding of the document or matter involved. Each statement in this prospectus, including statements
  incorporated by reference as discussed above, regarding a contract, agreement, or other document is qualified in its entirety by reference
  to the actual document.</P>
  
  <P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>
  
  <P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We are subject to periodic reporting and other
  informational requirements of the&nbsp;Exchange Act&nbsp;as applicable to foreign private issuers. Accordingly, we are required to file
  reports, including annual reports on Form 20-F, and other information with the SEC. All information filed with the SEC can be inspected
  over the Internet at the SEC&rsquo;s website at www.sec.gov and copied at the public reference facilities maintained by the SEC at 100
  F Street, N.E., Washington, D.C. 20549. You can request copies of these documents, upon payment of a duplicating fee, by writing to the
  SEC.</P>
  
  <P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As a foreign private issuer,
  we are exempt under the&nbsp;Exchange Act&nbsp;from, among other things, the rules prescribing the furnishing and content of proxy statements,
  and our executive officers, directors, and principal shareholders are exempt from the reporting and short-swing profit recovery provisions
  contained in Section 16 of the Exchange Act. In addition, we will not be required under the&nbsp;Exchange Act&nbsp;to file periodic or
  current reports and financial statements with the SEC as frequently or as promptly as U.S. companies whose securities are registered under
  the&nbsp;Exchange Act.</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B></B></P>
  
  <!-- Field: Page; Sequence: 10; Value: 1 -->
      <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
      <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
      <!-- Field: /Page -->
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PART II. INFORMATION REQUIRED IN THE REGISTRATION
  STATEMENT</B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Item 3. Incorporation of Documents by Reference.</B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The SEC allows us to &ldquo;incorporate by reference&rdquo;
  into this prospectus the documents we file with, or furnish to, it, which means that we can disclose important information to you by referring
  you to these documents. The information that we incorporate by reference into this prospectus forms a part of this prospectus, and information
  that we file later with the SEC automatically updates and supersedes any information in this prospectus. We incorporate by reference into
  this prospectus the documents listed below:</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
    <TR>
      <TD STYLE="vertical-align: bottom; width: 0.5in">&nbsp;</TD>
      <TD STYLE="vertical-align: top; width: 0.25in"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
      <TD STYLE="vertical-align: bottom; text-align: justify"><FONT STYLE="font-size: 10pt">our Annual report on&nbsp;</FONT><A HREF="http://www.sec.gov/Archives/edgar/data/1954269/000101376224003078/ea0209110-20f_garden.htm"><FONT STYLE="font-size: 10pt">Form 20-F</FONT></A><FONT STYLE="font-size: 10pt">&nbsp;for the fiscal year ended March 31, 2024, filed with the SEC on July 31, 2024;</FONT></TD></TR>
    <TR>
      <TD STYLE="vertical-align: bottom">&nbsp;</TD>
      <TD STYLE="vertical-align: top">&nbsp;</TD>
      <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD></TR>
    <TR>
      <TD STYLE="vertical-align: bottom">&nbsp;</TD>
      <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
      <TD STYLE="vertical-align: bottom; text-align: justify"><FONT STYLE="font-size: 10pt">our report of foreign private issuer on&nbsp;Form 6-K, furnished to the SEC on&nbsp;</FONT><A HREF="http://www.sec.gov/Archives/edgar/data/1954269/000121390023093093/ea189430-6k_gardenstage.htm"><FONT STYLE="font-size: 10pt">December 5, 2023</FONT></A><FONT STYLE="font-size: 10pt">,&nbsp;</FONT><A HREF="http://www.sec.gov/Archives/edgar/data/1954269/000121390024008740/ea192627-6k_gardenstage.htm"><FONT STYLE="font-size: 10pt">February 1, 2024</FONT></A><FONT STYLE="font-size: 10pt">,&nbsp;</FONT><A HREF="http://www.sec.gov/Archives/edgar/data/1954269/000121390024026883/ea0202809-6k_garden.htm"><FONT STYLE="font-size: 10pt">March 28, 2024</FONT></A><FONT STYLE="font-size: 10pt">,&nbsp;</FONT><A HREF="http://www.sec.gov/Archives/edgar/data/1954269/000121390024030619/ea0203389-6k_garden.htm"><FONT STYLE="font-size: 10pt">April 5, 2024</FONT></A><FONT STYLE="font-size: 10pt">, </FONT><A HREF="https://www.sec.gov/Archives/edgar/data/1954269/000121390025006303/ea0228527-6k_garden.htm"><FONT STYLE="font-size: 10pt">January 24, 2025</FONT></A><FONT STYLE="font-size: 10pt">, <A HREF="https://www.sec.gov/Archives/edgar/data/1954269/000121390025030350/ea0237673-6k_garden.htm">April 9, 2025</A> and <A HREF="https://www.sec.gov/Archives/edgar/data/1954269/000121390025031087/ea0237865-6k_garden.htm">April 11, 2025</A>;</FONT></TD></TR>
    <TR>
      <TD STYLE="vertical-align: bottom">&nbsp;</TD>
      <TD STYLE="vertical-align: top">&nbsp;</TD>
      <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD></TR>
    <TR>
      <TD STYLE="vertical-align: bottom">&nbsp;</TD>
      <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
      <TD STYLE="vertical-align: bottom; text-align: justify"><FONT STYLE="font-size: 10pt">the description of our ordinary shares contained in our registration statement on&nbsp;</FONT><A HREF="http://www.sec.gov/Archives/edgar/data/1954269/000121390023091377/ea188981-8a12b_gardenstage.htm"><FONT STYLE="font-size: 10pt">Form 8-A</FONT></A><FONT STYLE="font-size: 10pt">, filed with the SEC on November 30, 2023, and any amendment or report filed for the purpose of updating such description;</FONT></TD></TR>
    <TR>
      <TD STYLE="vertical-align: bottom">&nbsp;</TD>
      <TD STYLE="vertical-align: top">&nbsp;</TD>
      <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD></TR>
    <TR>
      <TD STYLE="vertical-align: bottom">&nbsp;</TD>
      <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
      <TD STYLE="vertical-align: bottom; text-align: justify"><FONT STYLE="font-size: 10pt">any future annual reports on Form 20-F filed with the SEC after the date of this prospectus and prior to the termination of the offering of the securities offered by this prospectus; and</FONT></TD></TR>
    <TR>
      <TD STYLE="vertical-align: bottom">&nbsp;</TD>
      <TD STYLE="vertical-align: top">&nbsp;</TD>
      <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD></TR>
    <TR>
      <TD STYLE="vertical-align: bottom">&nbsp;</TD>
      <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
      <TD STYLE="vertical-align: bottom; text-align: justify"><FONT STYLE="font-size: 10pt">any future reports of foreign private issuer on Form 6-K that we furnish to the SEC after the date of this prospectus that are identified in such reports as being incorporated by reference into the registration statement of which this prospectus forms a part.</FONT></TD></TR>
    </TABLE>
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our March 31, 2024, Annual
  Report contains a description of our business primarily through our subsidiaries in Hong Kong and audited consolidated financial statements
  with reports by our independent auditors. The consolidated financial statements are prepared and presented in accordance with U.S. GAAP.</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Any reports filed by us with
  the SEC after the date of this prospectus and before the date that the offering of securities by means of this prospectus is terminated
  will automatically update and, where applicable, supersede any information contained in this prospectus or incorporated by reference in
  this prospectus. This means that you must look at all of the SEC filings that we incorporate by reference to determine if any of the statements
  in this prospectus or in any documents incorporated by reference have been modified or superseded. Unless expressly incorporated by reference,
  nothing in this prospectus shall be deemed to incorporate by reference information furnished to, but not filed with, the SEC.</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We will provide without charge
  to any person (including any beneficial owner) to whom this prospectus is delivered, upon oral or written request, a copy of any document
  incorporated by reference in this prospectus but not delivered with the prospectus (except for exhibits to those documents unless a documents
  states that one of its exhibits is incorporated into the document itself). Such request should be directed to: Garden Stage Limited, 30th
  Floor, China Insurance Group Building, 141 Des Voeux Road Central, Central, Hong&nbsp;Kong; Tel: +852 2688 6333.</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Item 4. Description of Securities.</B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Not applicable.</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Item 5. Interests of Named Experts and Counsel.</B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Not applicable.</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>
  
  <!-- Field: Page; Sequence: 11; Options: NewSection; Value: 1 -->
      <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
      <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
      <!-- Field: /Page -->
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Item 6. Indemnification of Directors and Officers.</B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Cayman Islands law does not
  limit the extent to which a company&rsquo;s amended and restated memorandum and articles of association may provide for indemnification
  of officers and directors, except to the extent any such provision may be held by the Cayman Islands courts to be contrary to public policy,
  such as to provide indemnification against civil fraud or the consequences of committing a crime. Our amended and restated memorandum
  and articles of association provide for indemnification of officers and directors for losses, damages, costs and expenses incurred in
  their capacities as such unless such losses or damages arise from their own willful neglect or default.</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Insofar as indemnification
  for liabilities arising under the Securities Act may be permitted to our directors, officers or persons controlling us under the foregoing
  provisions, we have been informed that in the opinion of the SEC, such indemnification is against public policy as expressed in the Securities
  Act and is therefore unenforceable as a matter of United States law.</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Any underwriting agreement
  entered into in connection with an offering of securities will also provide for indemnification of us and our officers and directors in
  certain cases.</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Item 7. Exemption From Registration Claimed.</B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The grant of our securities
  were issued as compensation awards or as enticement or incentive awards. These grants were exempt from registration pursuant to Section
  4(2) of the Securities Act</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Item 8. Exhibits</B>&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following exhibits are
  filed as part of this registration statement:</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
    <TR STYLE="vertical-align: bottom">
      <TD STYLE="border-bottom: Black 1.5pt solid; width: 10%"><FONT STYLE="font-size: 10pt">Exhibit Number</FONT></TD>
      <TD STYLE="width: 2%; padding-bottom: 1pt">&nbsp;</TD>
      <TD STYLE="border-bottom: Black 1.5pt solid; width: 88%"><FONT STYLE="font-size: 10pt">Description of Document</FONT></TD></TR>
    <TR STYLE="background-color: rgb(204,238,255)">
      <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 10pt">5.1*</FONT></TD>
      <TD STYLE="vertical-align: top">&nbsp;</TD>
      <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-size: 10pt"><A HREF="ea024475001ex5-1_garden.htm">Opinion of&nbsp;Travers Thorp Alberga regarding the validity of the securities being registered</A></FONT></TD></TR>
    <TR STYLE="background-color: White">
      <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 10pt">10.1*</FONT></TD>
      <TD STYLE="vertical-align: top">&nbsp;</TD>
      <TD STYLE="vertical-align: top; text-align: justify"><A HREF="ea024475001ex10-1_garden.htm"><FONT STYLE="font-size: 10pt">Garden Stage Limited 2025 Equity Incentive Plan.</FONT></A></TD></TR>
    <TR STYLE="background-color: rgb(204,238,255)">
      <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 10pt">23.1*</FONT></TD>
      <TD STYLE="vertical-align: top">&nbsp;</TD>
      <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-size: 10pt"><A HREF="ea024475001ex23-1_garden.htm">Consent of J&amp;S Associate PLT</A></FONT></TD></TR>
    <TR STYLE="background-color: White">
      <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 10pt">23.2*</FONT></TD>
      <TD STYLE="vertical-align: top">&nbsp;</TD>
      <TD STYLE="vertical-align: top; text-align: justify"><A HREF="ea024475001ex23-2_garden.htm"><FONT STYLE="font-size: 10pt">Consent of Marcum Asia CPAs LLP</FONT></A></TD></TR>
    <TR STYLE="background-color: rgb(204,238,255)">
      <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 10pt">23.3*</FONT></TD>
      <TD STYLE="vertical-align: top">&nbsp;</TD>
      <TD STYLE="vertical-align: top; text-align: justify"><A HREF="ea024475001ex23-3_garden.htm"><FONT STYLE="font-size: 10pt">Consent of Friedman, LLP</FONT></A></TD></TR>
    <TR STYLE="background-color: White">
      <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 10pt">24.1*</FONT></TD>
      <TD STYLE="vertical-align: top">&nbsp;</TD>
      <TD STYLE="vertical-align: top; text-align: justify"><A HREF="#poa_001"><FONT STYLE="font-size: 10pt">Power of Attorney of the directors of the Registrant (contained in the signature pages hereto).</FONT></A></TD></TR>
    <TR STYLE="background-color: rgb(204,238,255)">
      <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 10pt">107*</FONT></TD>
      <TD STYLE="vertical-align: top">&nbsp;</TD>
      <TD STYLE="vertical-align: top; text-align: justify"><A HREF="ea024475001ex-fee_garden.htm"><FONT STYLE="font-size: 10pt">Filing Fee Table.</FONT></A></TD></TR>
    </TABLE>
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
    <TR STYLE="vertical-align: top">
      <TD STYLE="width: 24px; text-align: justify"><FONT STYLE="font-size: 10pt">*</FONT></TD>
      <TD><FONT STYLE="font-size: 10pt">Filed herewith.</FONT></TD></TR>
    </TABLE>
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>
  
  <!-- Field: Page; Sequence: 12; Value: 1 -->
      <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
      <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
      <!-- Field: /Page -->
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SIGNATURES</B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to the requirements
  of the Securities Act, the Company certifies that it has reasonable grounds to believe that it meets all of the requirements for filing
  on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized in
  Hong Kong, on the 10<SUP>th</SUP> of June, 2025.</P>
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
    <TR>
      <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD>
      <TD COLSPAN="2" STYLE="vertical-align: bottom; text-align: justify">GARDEN STAGE LIMITED</TD></TR>
    <TR>
      <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD>
      <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD>
      <TD>&nbsp;</TD></TR>
    <TR STYLE="vertical-align: bottom">
      <TD STYLE="width: 60%">&nbsp;</TD>
      <TD STYLE="width: 4%; text-align: justify"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
      <TD STYLE="border-bottom: Black 1.5pt solid; width: 36%"><FONT STYLE="font-size: 10pt">/s/&nbsp;<I>Sze Ho, CHAN</I></FONT></TD></TR>
    <TR STYLE="vertical-align: bottom">
      <TD>&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Sze Ho, CHAN</FONT></TD></TR>
    <TR STYLE="vertical-align: bottom">
      <TD>&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD><FONT STYLE="font-size: 10pt">Chief Executive Officer and<BR>
   Interim Chief Financial Officer<BR>
  (Principal Executive Officer and Principal Financial and Accounting Officer)</FONT></TD></TR>
    </TABLE>
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="poa_001"></A>Power of Attorney</B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Each person whose signature appears below constitutes
  and appoints each of Sze Ho CHAN as attorneys-in-fact&nbsp;with full power of substitution, for him or her in any and all capacities,
  to do any and all acts and all things and to execute any and all instruments which said attorney and agent may deem necessary or desirable
  to enable the registrant to comply with the Securities Act&nbsp;of&nbsp;1933, as amended (the &ldquo;Securities Act&rdquo;), and any rules,
  regulations, and requirements of the Securities and Exchange Commission thereunder, in connection with the registration under the Securities
  Act&nbsp;of&nbsp;ordinary shares of the registrant (the &ldquo;Shares&rdquo;), including, without limitation, the power and authority
  to sign the name of each of the undersigned in the capacities indicated below to the Registration Statement on Form&nbsp;S-8&nbsp;(the
  &ldquo;Registration Statement&rdquo;) to be filed with the Securities and Exchange Commission with respect to such Shares, to any and
  all amendments or supplements to such Registration Statement, whether such amendments or supplements are filed before or after the effective
  date of such Registration Statement, to any related Registration Statement filed pursuant to Rule&nbsp;462(b)&nbsp;under the Securities
  Act, and to any and all instruments or documents filed as part of or in connection with such Registration Statement or any and all amendments
  thereto, whether such amendments are filed before or after the effective date of such Registration Statement; and each of the undersigned
  hereby ratifies and confirms all that such attorney and agent shall do or cause to be done by virtue hereof.</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
    <TR STYLE="vertical-align: bottom">
      <TD STYLE="width: 36%; border-bottom: black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Name</B></FONT></TD>
      <TD STYLE="white-space: nowrap; width: 1%">&nbsp;</TD>
      <TD STYLE="width: 47%; border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Title</B></FONT></TD>
      <TD STYLE="white-space: nowrap; width: 1%">&nbsp;</TD>
      <TD STYLE="width: 15%; border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Date</B></FONT></TD></TR>
    <TR STYLE="vertical-align: bottom">
      <TD>&nbsp;</TD>
      <TD STYLE="white-space: nowrap">&nbsp;</TD>
      <TD STYLE="text-align: center">&nbsp;</TD>
      <TD STYLE="white-space: nowrap">&nbsp;</TD>
      <TD STYLE="text-align: center">&nbsp;</TD></TR>
    <TR STYLE="vertical-align: bottom">
      <TD STYLE="border-bottom: black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/&nbsp;Sze Ho, CHAN</I></FONT></TD>
      <TD STYLE="white-space: nowrap">&nbsp;</TD>
      <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer, Director, and Interim&nbsp;Chief Financial Officer</FONT></TD>
      <TD STYLE="white-space: nowrap">&nbsp;</TD>
      <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">June 10, 2025</FONT></TD></TR>
    <TR>
      <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sze Ho, CHAN</FONT></TD>
      <TD STYLE="white-space: nowrap; vertical-align: bottom">&nbsp;</TD>
      <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Principal Executive Officer and Principal Financial and Accounting Officer)</FONT></TD>
      <TD STYLE="white-space: nowrap; vertical-align: bottom">&nbsp;</TD>
      <TD STYLE="vertical-align: bottom">&nbsp;</TD></TR>
    <TR STYLE="vertical-align: bottom">
      <TD>&nbsp;</TD>
      <TD STYLE="white-space: nowrap">&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD STYLE="white-space: nowrap">&nbsp;</TD>
      <TD>&nbsp;</TD></TR>
    <TR STYLE="vertical-align: bottom">
      <TD STYLE="border-bottom: black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/&nbsp;Ngan Sammy, SHUM</I></FONT></TD>
      <TD STYLE="white-space: nowrap">&nbsp;</TD>
      <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
      <TD STYLE="white-space: nowrap">&nbsp;</TD>
      <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">June 10, 2025</FONT></TD></TR>
    <TR STYLE="vertical-align: bottom">
      <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ngan Sammy, SHUM</FONT></TD>
      <TD STYLE="white-space: nowrap">&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD STYLE="white-space: nowrap">&nbsp;</TD>
      <TD>&nbsp;</TD></TR>
    <TR STYLE="vertical-align: bottom">
      <TD STYLE="text-align: justify">&nbsp;</TD>
      <TD STYLE="white-space: nowrap">&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD STYLE="white-space: nowrap">&nbsp;</TD>
      <TD>&nbsp;</TD></TR>
    <TR STYLE="vertical-align: bottom">
      <TD STYLE="border-bottom: black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/ Sheung Chi Steven, WU</I></FONT></TD>
      <TD STYLE="white-space: nowrap">&nbsp;</TD>
      <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
      <TD STYLE="white-space: nowrap">&nbsp;</TD>
      <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">June 10, 2025</FONT></TD></TR>
    <TR STYLE="vertical-align: bottom">
      <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sheung Chi Steven, WU</FONT></TD>
      <TD STYLE="white-space: nowrap">&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD STYLE="white-space: nowrap">&nbsp;</TD>
      <TD>&nbsp;</TD></TR>
    <TR STYLE="vertical-align: bottom">
      <TD STYLE="text-align: justify">&nbsp;</TD>
      <TD STYLE="white-space: nowrap">&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD STYLE="white-space: nowrap">&nbsp;</TD>
      <TD>&nbsp;</TD></TR>
    <TR STYLE="vertical-align: bottom">
      <TD STYLE="border-bottom: black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/ B Ray Billy, TAM</I></FONT></TD>
      <TD STYLE="white-space: nowrap">&nbsp;</TD>
      <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
      <TD STYLE="white-space: nowrap">&nbsp;</TD>
      <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">June 10, 2025</FONT></TD></TR>
    <TR STYLE="vertical-align: bottom">
      <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">B Ray Billy, TAM</FONT></TD>
      <TD STYLE="white-space: nowrap">&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD STYLE="white-space: nowrap">&nbsp;</TD>
      <TD>&nbsp;</TD></TR>
    <TR STYLE="vertical-align: bottom">
      <TD STYLE="text-align: justify">&nbsp;</TD>
      <TD STYLE="white-space: nowrap">&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD STYLE="white-space: nowrap">&nbsp;</TD>
      <TD>&nbsp;</TD></TR>
    <TR STYLE="vertical-align: bottom">
      <TD STYLE="border-bottom: black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/ Kevin, GUAN</I></FONT></TD>
      <TD STYLE="white-space: nowrap">&nbsp;</TD>
      <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
      <TD STYLE="white-space: nowrap">&nbsp;</TD>
      <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">June 10, 2025</FONT></TD></TR>
    <TR STYLE="vertical-align: bottom">
      <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Kevin, GUAN</FONT></TD>
      <TD STYLE="white-space: nowrap">&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD STYLE="white-space: nowrap">&nbsp;</TD>
      <TD>&nbsp;</TD></TR>
    <TR STYLE="vertical-align: bottom">
      <TD STYLE="text-align: justify">&nbsp;</TD>
      <TD STYLE="white-space: nowrap">&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD STYLE="white-space: nowrap">&nbsp;</TD>
      <TD>&nbsp;</TD></TR>
    <TR STYLE="vertical-align: bottom">
      <TD STYLE="border-bottom: black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/ Kit Wa, TO</I></FONT></TD>
      <TD STYLE="white-space: nowrap">&nbsp;</TD>
      <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
      <TD STYLE="white-space: nowrap">&nbsp;</TD>
      <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">June 10, 2025</FONT></TD></TR>
    <TR STYLE="vertical-align: bottom">
      <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Kit Wa, TO</FONT></TD>
      <TD STYLE="white-space: nowrap">&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD STYLE="white-space: nowrap">&nbsp;</TD>
      <TD>&nbsp;</TD></TR>
    </TABLE>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>
  
  <P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>
  
  <P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>
  
  <P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">II-3</P>
  
  <!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  </BODY>
  </HTML>
metadata_documents: [{"type": "S-8", "sequence": "1", "filename": "ea024475001-s8_garden.htm", "description": "REGISTRATION STATEMENT", "secsgml_size_bytes": 74836}]
metadata_filer: {"company-data": {"conformed-name": "Garden Stage Ltd", "cik": "0001954269", "assigned-sic": "6200", "organization-name": "09 Crypto Assets", "ein": "000000000", "state-of-incorporation": "E9", "fiscal-year-end": "0331"}, "filing-values": {"form-type": "S-8", "act": "33", "file-number": "333-287932", "film-number": "251038303"}, "business-address": {"street1": "201, 2/F, CHINA INSURANCE GROUP BUILDING", "street2": "141 DES VOEUX ROAD CENTRAL", "city": "HONG KONG", "state": "K3", "zip": "000", "phone": "00852 2688 6333"}, "mail-address": {"street1": "201, 2/F, CHINA INSURANCE GROUP BUILDING", "street2": "141 DES VOEUX ROAD CENTRAL", "city": "HONG KONG", "state": "K3", "zip": "000"}}
text: As filed with the U.S. Securities and Exchange
  Commission on June 10, 2025
  Registration No. 333-[_____]
  UNITED STATES
  SECURITIES AND
  EXCHANGE COMMISSION
  Washington, D.C. 20549
  FORM S-8
  REGISTRATION STATEMENT UNDER THE SECURITIES
  ACT OF 1933
  GARDEN STAGE LIMITED
  (Exact name of registrant as specified in its charter)
  Cayman Islands
  Not Applicable
  (State or other jurisdiction of
  incorporation or organization)
  (I.R.S. Employer
  Identification No.)
  Sze Ho, CHAN
  Chief Executive Officer, Director and
  Interim Chief Financial Officer
  Garden Stage Limited
  30
  th
  Floor, China Insurance Group
  Building
  141 Des Vouex Road Central
  Central, Hong Kong
  (Address, including zip code, and telephone number,
  including area code, of registrant's principal executive office)
  Garden Stage Limited
  2025 Equity Incentive Plan
  (Full title of the plan)
  Cogency Global Inc.
  122 East 42nd Street, 18th Floor
  New York, NY 10168
  (Name and address of agent for service)
  Tel: +852 2688 6333
  (Telephone number, including area code, of agent
  for service)
  Copies to:
  Shane Wu, Esq.
  Ross D. Carmel, Esq.
  Sichenzia Ross Ference Carmel LLP
  1185 Avenue of the Americas, 31
  st
  Floor
  New York, NY 10036
  Telephone: (212) 930-9700
  Indicate by check mark whether the registrant
  is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of "large
  accelerated filer," "accelerated filer" and "smaller reporting company" in Rule 12b-2 of the Exchange Act.
  Large accelerated filer
  ☐
  Accelerated filer
  ☐
  Non-accelerated filer
  ☒
  Smaller reporting company
  ☒
  Emerging growth company
  ☒
  If an emerging growth company, indicate by check
  mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
  standards provided pursuant to Section 7(a)(2)(B) of the Securities Act
  ☐
  EXPLANATORY NOTE
  This registration statement
  on Form S-8 (the "Registration Statement") relates to an additional 5,900,000 ordinary shares, par value $0.0001 per share
  of Garden Stage Limited (the "Registrant," the "Company," "we," "us" or "our"),
  which are issuable pursuant to awards that may be granted under our Equity Incentive Plan, as amended (the "Plan"). There
  may be additional shares that will become reserved for issuance as a result of the operation of the "evergreen" provision
  in the Plan. Under the Plan, a total of 5,900,000 ordinary shares have been reserved for issuance upon the grant of awards and exercise
  of options to directors, officers, employees and consultants of the Company and of the Company's affiliates, subject to increase
  under the "evergreen" provision in the plan. Pursuant to General Instruction E to Form S-8, the contents of the Registrant's
  Prior Registration Statements are incorporated herein by reference except to the extent supplemented, amended or superseded by the information
  set forth herein. Only those items of Form S-8 containing new information not contained in the earlier registration statement are presented
  herein. Only those items of Form S-8 containing new information not contained in the Prior Registration Statements are presented herein.
  PART I
  INFORMATION REQUIRED IN THE SECTION 10(a) PROSPECTUS
  Item 1. Plan Information
  The documents containing the
  information specified in Part I, and the Note to Part I of Form S-8 will be delivered to each of the participants in accordance with Rule
  428 under the Securities Act of 1933, as amended (the "Securities Act"), but these documents and the documents incorporated
  by reference in this Registration Statement pursuant to Item 3 of Part II of this Registration Statement, taken together, constitute a
  Prospectus that meets the requirements of Section 10(a) of the Securities Act.
  Item 2. Registrant Information and Employee
  Plan Annual Information.
  Upon written or oral request,
  any of the documents incorporated by reference in Item 3 of Part II of this Registration Statement (which documents are incorporated by
  reference in this Section 10(a) Prospectus) and other documents required to be delivered to eligible employers, non-employee directors
  and consultants pursuant to Rule 428(b) are available without charge by contacting: Chan Sze Ho, Chief Executive Officer of Garden Stage
  Limited, 30th Floor, China Insurance Group Building, 141 Des Voeux Road Central, Central, Hong Kong at +852 2688 6333.
  1
  Investment in our ordinary
  shares involves a high degree of risk. See "Risk Factors" contained in this prospectus, in our periodic reports filed from
  time to time with the Securities and Exchange Commission (the "SEC"), which are incorporated by reference in this prospectus,
  and in any applicable prospectus supplement. You should carefully read this prospectus and the documents we incorporate by reference,
  before you invest in our ordinary shares.
  Neither the SEC nor any
  state securities commission has approved or disapproved of these securities or passed upon the adequacy or the accuracy of this prospectus.
  Any representation to the contrary is a criminal offense.
  The date of this Prospectus is June 10, 2025.
  2
  TABLE OF CONTENTS
  Page
  Special Note Regarding Forward-Looking Statements
  4
  Risk Factors
  5
  Legal Matters
  5
  Experts
  5
  Incorporation of Documents by Reference
  6
  Disclosure of Commission Position on Indemnification for Securities Act Liabilities
  7
  3
  SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS
  This prospectus and
  any prospectus supplement contains forward-looking statements, about our expectations, beliefs or intentions regarding, among other things,
  our product development efforts, business, financial condition, results of operations, strategies or prospects. In addition, from time
  to time, our representatives have made or may make forward-looking statements, orally or in writing. Forward-looking statements can be
  identified by the use of forward-looking words such as "believe," "expect," "intend," "plan,"
  "may," "should" or "anticipate" or their negatives or other variations of these words or other comparable
  words or by the fact that these statements do not relate strictly to historical or current matters. These forward-looking statements may
  be included in, but are not limited to, various filings made by us with the SEC, press releases or oral statements made by or with the
  approval of one of our authorized executive officers. Forward-looking statements relate to anticipated or expected events, activities,
  trends or results as of the date they are made. Because forward-looking statements relate to matters that have not yet occurred, these
  statements are inherently subject to risks and uncertainties that could cause our actual results to differ materially from any future
  results expressed or implied by the forward-looking statements. Many factors could cause our actual activities or results to differ materially
  from the activities and results anticipated in forward-looking statements, including, but not limited to, the factors summarized below.
  This prospectus identifies
  important factors which could cause our actual results to differ materially from those indicated by the forward-looking statements, particularly
  those set forth under the heading "Risk Factors," beginning on page 5 of this prospectus. The risk factors included in this
  prospectus are not necessarily all of the important factors that could cause actual results to differ materially from those expressed
  in any of our forward-looking statements. Given these uncertainties, you are cautioned not to place undue reliance on such forward-looking
  statements.
  All forward-looking statements
  attributable to us or persons acting on our behalf speak only as of the date of this prospectus and are expressly qualified in their entirety
  by the cautionary statements included in this prospectus. We undertake no obligations to update or revise forward-looking statements to
  reflect events or circumstances that arise after the date made or to reflect the occurrence of unanticipated events. In evaluating forward-looking
  statements, you should consider these risks and uncertainties.
  4
  RISK FACTORS
  An investment in our Ordinary
  Shares involves risks. Prior to making a decision about investing in our ordinary shares, you should consider carefully all of the information
  contained or incorporated by reference in this prospectus, including any risks in the section entitled "Risk Factors" contained
  in any supplements to this prospectus and in our registration statement on Form F-3 (Registration No. 333-283618) filed on February 18,
  2025, which went effective on March 10, 2025, and in our subsequent filings with the SEC. Each of the referenced risks and uncertainties
  could adversely affect our business, operating results and financial condition, as well as adversely affect the value of an investment
  in our securities. Additional risks not known to us or that we believe are immaterial may also adversely affect our business, operating
  results and financial condition and the value of an investment in our securities.
  LEGAL MATTERS
  The validity of the securities
  offered by this prospectus will be passed upon by Sichenzia Ross Ference Carmel LLP, New York, New York.
  EXPERTS
  The consolidated financial statements for the years
  ended March 31, 2024, incorporated by reference in this prospectus have been so included in reliance on the report of J&S Associate
  PLT, an independent registered public accounting firm, given on their authority as experts in accounting and auditing. The office of J&S
  Associate PLT is located at B-11-14, Megan Avenue II 12, Jalan Yap Kwan Seng, 50450, Kuala Lumpur, Malaysia.
  The consolidated financial statements as of and
  for the year ended March 31, 2023, incorporated by reference in this prospectus have been so included in reliance on the report of
  Marcum Asia CPAs LLP, an independent registered public accounting firm, given on their authority as experts in accounting and auditing.
  The office of Marcum Asia CPAs LLP is located at 7 Penn Plaza Suite 830, New York, NY 10001.
  The consolidated financial statements for the year
  ended March 31, 2022, incorporated by reference in this prospectus have been so included in reliance on the report of Friedman LLP an
  independent registered public accounting firm, given on their authority as experts in accounting and auditing. Friedman LLP was merged
  with Marcum LLP on September 1, 2022, and filed its application to withdraw the PCAOB registration on December 30, 2022.
  5
  INCORPORATION OF CERTAIN INFORMATION BY REFERENCE
  The SEC allows us to "incorporate by reference"
  into this prospectus the documents we file with, or furnish to, it, which means that we can disclose important information to you by referring
  you to these documents. The information that we incorporate by reference into this prospectus forms a part of this prospectus, and information
  that we file later with the SEC automatically updates and supersedes any information in this prospectus. We incorporate by reference into
  this prospectus the documents listed below:
  ●
  our Annual report on
  Form 20-F
  for the fiscal year ended March 31, 2024, filed with the SEC on July 31, 2024;
  ●
  our report of foreign private issuer on Form 6-K, furnished to the SEC on
  December 5, 2023
  ,
  February 1, 2024
  ,
  March 28, 2024
  ,
  April 5, 2024
  ,
  January 24, 2025
  ,
  April 9, 2025
  and
  April 11, 2025
  ;
  ●
  the description of our ordinary shares contained in our registration statement on
  Form 8-A
  , filed with the SEC on November 30, 2023, and any amendment or report filed for the purpose of updating such description;
  ●
  any future annual reports on Form 20-F filed with the SEC after the date of this prospectus and prior to the termination of the offering of the securities offered by this prospectus; and
  ●
  any future reports of foreign private issuer on Form 6-K that we furnish to the SEC after the date of this prospectus that are identified in such reports as being incorporated by reference into the registration statement of which this prospectus forms a part.
  Our March 31, 2024, Annual Report contains a description
  of our business primarily through our subsidiaries in Hong Kong and audited consolidated financial statements with reports by our independent
  auditors. The consolidated financial statements are prepared and presented in accordance with U.S. GAAP.
  Any reports filed by us with the SEC after the
  date of this prospectus and before the date that the offering of securities by means of this prospectus is terminated will automatically
  update and, where applicable, supersede any information contained in this prospectus or incorporated by reference in this prospectus.
  This means that you must look at all of the SEC filings that we incorporate by reference to determine if any of the statements in this
  prospectus or in any documents incorporated by reference have been modified or superseded. Unless expressly incorporated by reference,
  nothing in this prospectus shall be deemed to incorporate by reference information furnished to, but not filed with, the SEC.
  We will provide without charge to any person (including
  any beneficial owner) to whom this prospectus is delivered, upon oral or written request, a copy of any document incorporated by reference
  in this prospectus but not delivered with the prospectus (except for exhibits to those documents unless a documents states that one of
  its exhibits is incorporated into the document itself). Such request should be directed to: Garden Stage Limited, 30th Floor, China Insurance
  Group Building, 141 Des Voeux Road Central, Central, Hong Kong; Tel: +852 2688 6333.
  6
  DISCLOSURE OF COMMISSION POSITION ON INDEMNIFICATION
  FOR SECURITIES ACT LIABILITIES
  Insofar as indemnification
  for liabilities arising under the Securities Act may be permitted to directors, officers or persons controlling the registrant, the registrant
  has been informed that in the opinion of the SEC such indemnification is against public policy as expressed in the Securities Act and
  is therefore unenforceable.
  7
  WHERE YOU CAN FIND MORE INFORMATION
  As permitted by SEC rules, this prospectus omits
  certain information and exhibits that are included in the registration statement of which this prospectus forms a part. Since this prospectus
  may not contain all of the information that you may find important, you should review the full text of these documents. If we have filed
  a contract, agreement, or other document as an exhibit to the registration statement of which this prospectus forms a part, you should
  read the exhibit for a more complete understanding of the document or matter involved. Each statement in this prospectus, including statements
  incorporated by reference as discussed above, regarding a contract, agreement, or other document is qualified in its entirety by reference
  to the actual document.
  We are subject to periodic reporting and other
  informational requirements of the Exchange Act as applicable to foreign private issuers. Accordingly, we are required to file
  reports, including annual reports on Form 20-F, and other information with the SEC. All information filed with the SEC can be inspected
  over the Internet at the SEC's website at www.sec.gov and copied at the public reference facilities maintained by the SEC at 100
  F Street, N.E., Washington, D.C. 20549. You can request copies of these documents, upon payment of a duplicating fee, by writing to the
  SEC.
  As a foreign private issuer,
  we are exempt under the Exchange Act from, among other things, the rules prescribing the furnishing and content of proxy statements,
  and our executive officers, directors, and principal shareholders are exempt from the reporting and short-swing profit recovery provisions
  contained in Section 16 of the Exchange Act. In addition, we will not be required under the Exchange Act to file periodic or
  current reports and financial statements with the SEC as frequently or as promptly as U.S. companies whose securities are registered under
  the Exchange Act.
  8
  PART II. INFORMATION REQUIRED IN THE REGISTRATION
  STATEMENT
  Item 3. Incorporation of Documents by Reference.
  The SEC allows us to "incorporate by reference"
  into this prospectus the documents we file with, or furnish to, it, which means that we can disclose important information to you by referring
  you to these documents. The information that we incorporate by reference into this prospectus forms a part of this prospectus, and information
  that we file later with the SEC automatically updates and supersedes any information in this prospectus. We incorporate by reference into
  this prospectus the documents listed below:
  ●
  our Annual report on
  Form 20-F
  for the fiscal year ended March 31, 2024, filed with the SEC on July 31, 2024;
  ●
  our report of foreign private issuer on Form 6-K, furnished to the SEC on
  December 5, 2023
  ,
  February 1, 2024
  ,
  March 28, 2024
  ,
  April 5, 2024
  ,
  January 24, 2025
  ,
  April 9, 2025
  and
  April 11, 2025
  ;
  ●
  the description of our ordinary shares contained in our registration statement on
  Form 8-A
  , filed with the SEC on November 30, 2023, and any amendment or report filed for the purpose of updating such description;
  ●
  any future annual reports on Form 20-F filed with the SEC after the date of this prospectus and prior to the termination of the offering of the securities offered by this prospectus; and
  ●
  any future reports of foreign private issuer on Form 6-K that we furnish to the SEC after the date of this prospectus that are identified in such reports as being incorporated by reference into the registration statement of which this prospectus forms a part.
  Our March 31, 2024, Annual
  Report contains a description of our business primarily through our subsidiaries in Hong Kong and audited consolidated financial statements
  with reports by our independent auditors. The consolidated financial statements are prepared and presented in accordance with U.S. GAAP.
  Any reports filed by us with
  the SEC after the date of this prospectus and before the date that the offering of securities by means of this prospectus is terminated
  will automatically update and, where applicable, supersede any information contained in this prospectus or incorporated by reference in
  this prospectus. This means that you must look at all of the SEC filings that we incorporate by reference to determine if any of the statements
  in this prospectus or in any documents incorporated by reference have been modified or superseded. Unless expressly incorporated by reference,
  nothing in this prospectus shall be deemed to incorporate by reference information furnished to, but not filed with, the SEC.
  We will provide without charge
  to any person (including any beneficial owner) to whom this prospectus is delivered, upon oral or written request, a copy of any document
  incorporated by reference in this prospectus but not delivered with the prospectus (except for exhibits to those documents unless a documents
  states that one of its exhibits is incorporated into the document itself). Such request should be directed to: Garden Stage Limited, 30th
  Floor, China Insurance Group Building, 141 Des Voeux Road Central, Central, Hong Kong; Tel: +852 2688 6333.
  Item 4. Description of Securities.
  Not applicable.
  Item 5. Interests of Named Experts and Counsel.
  Not applicable.
  II-
  1
  Item 6. Indemnification of Directors and Officers.
  Cayman Islands law does not
  limit the extent to which a company's amended and restated memorandum and articles of association may provide for indemnification
  of officers and directors, except to the extent any such provision may be held by the Cayman Islands courts to be contrary to public policy,
  such as to provide indemnification against civil fraud or the consequences of committing a crime. Our amended and restated memorandum
  and articles of association provide for indemnification of officers and directors for losses, damages, costs and expenses incurred in
  their capacities as such unless such losses or damages arise from their own willful neglect or default.
  Insofar as indemnification
  for liabilities arising under the Securities Act may be permitted to our directors, officers or persons controlling us under the foregoing
  provisions, we have been informed that in the opinion of the SEC, such indemnification is against public policy as expressed in the Securities
  Act and is therefore unenforceable as a matter of United States law.
  Any underwriting agreement
  entered into in connection with an offering of securities will also provide for indemnification of us and our officers and directors in
  certain cases.
  Item 7. Exemption From Registration Claimed.
  The grant of our securities
  were issued as compensation awards or as enticement or incentive awards. These grants were exempt from registration pursuant to Section
  4(2) of the Securities Act
  Item 8. Exhibits
  The following exhibits are
  filed as part of this registration statement:
  Exhibit Number
  Description of Document
  5.1*
  Opinion of Travers Thorp Alberga regarding the validity of the securities being registered
  10.1*
  Garden Stage Limited 2025 Equity Incentive Plan.
  23.1*
  Consent of J&S Associate PLT
  23.2*
  Consent of Marcum Asia CPAs LLP
  23.3*
  Consent of Friedman, LLP
  24.1*
  Power of Attorney of the directors of the Registrant (contained in the signature pages hereto).
  107*
  Filing Fee Table.
  *
  Filed herewith.
  II-
  2
  SIGNATURES
  Pursuant to the requirements
  of the Securities Act, the Company certifies that it has reasonable grounds to believe that it meets all of the requirements for filing
  on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized in
  Hong Kong, on the 10
  th
  of June, 2025.
  GARDEN STAGE LIMITED
  By:
  /s/
  Sze Ho, CHAN
  Sze Ho, CHAN
  Chief Executive Officer and
  Interim Chief Financial Officer
  (Principal Executive Officer and Principal Financial and Accounting Officer)
  Power of Attorney
  Each person whose signature appears below constitutes
  and appoints each of Sze Ho CHAN as attorneys-in-fact with full power of substitution, for him or her in any and all capacities,
  to do any and all acts and all things and to execute any and all instruments which said attorney and agent may deem necessary or desirable
  to enable the registrant to comply with the Securities Act of 1933, as amended (the "Securities Act"), and any rules,
  regulations, and requirements of the Securities and Exchange Commission thereunder, in connection with the registration under the Securities
  Act of ordinary shares of the registrant (the "Shares"), including, without limitation, the power and authority
  to sign the name of each of the undersigned in the capacities indicated below to the Registration Statement on Form S-8 (the
  "Registration Statement") to be filed with the Securities and Exchange Commission with respect to such Shares, to any and
  all amendments or supplements to such Registration Statement, whether such amendments or supplements are filed before or after the effective
  date of such Registration Statement, to any related Registration Statement filed pursuant to Rule 462(b) under the Securities
  Act, and to any and all instruments or documents filed as part of or in connection with such Registration Statement or any and all amendments
  thereto, whether such amendments are filed before or after the effective date of such Registration Statement; and each of the undersigned
  hereby ratifies and confirms all that such attorney and agent shall do or cause to be done by virtue hereof.
  Name
  Title
  Date
  /s/ Sze Ho, CHAN
  Chief Executive Officer, Director, and Interim Chief Financial Officer
  June 10, 2025
  Sze Ho, CHAN
  (Principal Executive Officer and Principal Financial and Accounting Officer)
  /s/ Ngan Sammy, SHUM
  Director
  June 10, 2025
  Ngan Sammy, SHUM
  /s/ Sheung Chi Steven, WU
  Director
  June 10, 2025
  Sheung Chi Steven, WU
  /s/ B Ray Billy, TAM
  Director
  June 10, 2025
  B Ray Billy, TAM
  /s/ Kevin, GUAN
  Director
  June 10, 2025
  Kevin, GUAN
  /s/ Kit Wa, TO
  Director
  June 10, 2025
  Kit Wa, TO
  II-3